Carey K. Anders

Carey K. Anders is an American cancer researcher, professor of medicine

Anders studies the genetic sequencing, prognosis and treatment of brain metastasis and its relationship to primary forms of cancer, in particular breast cancer. including triple negative and HER2-positive breast cancer. and worked in Burlington, North Carolina.

Kernodle received her M.D. from the Brody School of Medicine at East Carolina University in 2002. She then held an Internal Medicine Residency at the Duke University School of Medicine from 2002 to 2005, followed by a Hematololgy-Oncology Fellowship from 2005 to 2008.

Career In 2008 Anders joined the School of Medicine of the University of North Carolina at Chapel Hill, where she worked with the UNC Lineberger Comprehensive Cancer Center. She has served as medical director of the UNC Breast Center and as an associate professor at UNC's School of Medicine in the Division of Hematology/Oncology.

In January 2019, Anders returned to the School of Medicine at Duke University Health System as a Translating Duke Health Scholar, a professor of medicine, and the Medical Director for the Duke Center for Brain and Spine Metastasis (DCBSM). In addition to being Medical Director, Anders served as Chief of the Division of Medical Oncology from 2021 to 2025.

Awards and honors 2011, Weatherspoon Family Brain Tumor Research Award 2011, Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research 2012, Clinical Investigator Award, Damon Runyon Cancer Research Foundation. 2016, Advanced Clinical Research Award (ACRA) in Breast Cancer, Conquer Cancer Foundation 2018-2019, Leadership Development Program, American Society of Clinical Oncology 2021, Clinical Cancer Advances, American Society of Clinical Oncology 2021, Women in Leadership Nominee, Women Leaders in Oncology 2023, Fellow, American Society of Clinical Oncology 2024, Chair's Commitment to Excellence Award, Duke University

Selected publications